Subscribe to
this category


A total of 61 posts are filed under Deals
Eiger Expands License Agreement with Merck, Enters Agreement with Progeria Research Foundation
Rare Daily Staff Eiger BioPharmaceuticals said it has expanded its licensing agreement with Merck to include rights to develop the… Continue Reading
Amryt and Aegerion Expand Agreement for HoFH Drug in Russia, CIS, and Non-E.U. Balkan States
Rare Daily Staff Amryt said that it expanded its exclusive license agreement with Aegerion Pharmaceuticals for the rare cholesterol disorder… Continue Reading
Takeda Agrees to Acquire Shire for $62.4 Billion
Rare Daily Staff Takeda Pharmaceutical and Shire said that they have reached agreement on the terms for Takeda to acquire the rare disease… Continue Reading
Sarepta Enters Gene Therapy Partnership with Myonexus for up to $105 Million, Option to Acquire
Rare Daily Staff Sarepta Therapeutics said it has entered into an exclusive partnership worth up to $105 million with Myonexus Therapeutics… Continue Reading
Spark Sells Priority Review Voucher to Jazz for $110 Million
Rare Daily Staff Spark Therapeutics said it has entered into an agreement to sell its rare pediatric disease priority review voucher to Jazz… Continue Reading
Takeda Closes in on Shire with $64 Billion Bid
Rare Daily Staff The board of rare disease drugmaker Shire said it is prepared to recommend that shareholders accept a sweetened $64 billion… Continue Reading
Dicerna to Pay Alnylam $25 Million as Part of Litigation Settlement
Rare Daily Staff Alnylam Pharmaceuticals and Dicerna Pharmaceuticals said they have resolved all litigation relating to lawsuits filed… Continue Reading
1 2 3 9

Follow us on Twitter